A Study of ADX-102 in Subjects With Allergic Conjunctivitis

Clinical trial NCT03012165 · COMPLETED

Trial details

NCT number: NCT03012165
Sponsor: Aldeyra Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Conjunctivitis, Allergic

Start date: 2016-12-01
Primary completion: 2017-05-01
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.